Lacerta Therapeutics Competitors and Similar CompaniesClear all
Lacerta Therapeutics's competitors and similar companies include Taysha Gene Therapies, Nouscom, StrideBio and Dyne Therapeutics.
 Nouscom Nouscom is a biotech company working to develop a series of new, potent immunotherapeutics capable of selectively killing tumor cells.
|  StrideBio StrideBio is a gene therapy company focused on creating and developing novel adeno-associated viral vector technologies and therapeutics for rare diseases. |  Dyne Therapeutics Dyne Therapeutics is a biotechnology company which is engaged in the development of targeted therapies for patients with serious muscle diseases. | |||
Founding Date | Founding Date 2017 | Founding Date 2020 | Founding Date 2015 | Founding Date 2015 | Founding Date 2018 |
Type | Type Private | Type Public | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations Alachua, US HQ Alachua, US | Locations Dallas, US HQ | Locations Basel, CH HQ Roma, IT | Locations US HQ | Locations Waltham, US HQ |
Employees | Employees 13 | Employees 5220% decrease | Employees 633% increase | Employees 5 | Employees 1451% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 385.3 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 3.1 b |
Financial | |||||
Net income | Net income N/A | Net income ($109m) (FY, 2025) | Net income N/A | Net income N/A | Net income ($446.2m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round $ 30m (almost 8 years ago) | Latest funding round N/A | Latest funding round $ 49m (over 8 years ago) | Latest funding round $ 81.5m (about 5 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 30m | Total funding raised $ 125m | Total funding raised $ 62.6m | Total funding raised $ 97.2m | Total funding raised $ 165m |
For sources of this data, please see the company profile
View Company Profiles
Taysha Gene Therapies
HQ
Dallas, US
Employees
52↓ 20% decrease
Taysha Gene Therapies is a biotechnology company that develops therapies.
View companyNouscom
HQ
Basel, CH
Employees
63↑ 3% increase
Nouscom is a biotech company working to develop a series of new, potent immunotherapeutics capable of selectively killing tumor cells.
View companyStrideBio
HQ
US
Employees
5
StrideBio is a gene therapy company focused on creating and developing novel adeno-associated viral vector technologies and therapeutics for rare diseases.
View companyDyne Therapeutics
HQ
Waltham, US
Employees
145↓ 1% decrease
Dyne Therapeutics is a biotechnology company which is engaged in the development of targeted therapies for patients with serious muscle diseases.
View company